Glycine Market Size & Outlook, 2026-2034

Glycine Market Overview

The global glycine market size is valued at USD 2.38 billion in 2025 and is projected to reach USD 4.15 billion by 2034, expanding at a CAGR of 6.4% during the forecast period. The market growth is driven by rising demand from pharmaceuticals, animal nutrition, food and beverages, and agrochemicals, supported by expanding healthcare needs, growth in protein consumption, regulatory emphasis on product safety, and increasing use of amino acids in industrial and specialty chemical applications.

Key Market Trends & Insights

• Asia Pacific dominated the market with a revenue share of 44.2% in 2025.
• Middle East and Africa is anticipated to grow at the fastest CAGR of 7.8% during the forecast period.
• Based on Grade, the Pharmaceutical-grade glycinesegment held the highest market share of 38.4% in 2025.
• By Application, the Animal feed and nutritionsegment is estimated to register the fastest CAGR growth of 7.6%.
• Based on Production Method,the Synthetic glycine production category dominated the market in 2025 with a revenue share of 65%.
• Based on Distribution Channel, the Distributors and traderssegment is projected to register the fastest CAGR of 7.1% during the forecast period.
• China dominates the market, valued at USD 526.94 million in 2025 and reaching USD 558.76 million in 2026.

China Glycine Market Size (USD Million)

Source: Straits Research

Market Revenue Figures

• 2025 Market Size: USD 2.38 billion
• 2034 Projected Market Size: USD 4.15 billion
• CAGR (2026-2034): 6.4%
• Dominating Region: Asia Pacific
• Fastest-Growing Region: Middle East and Africa

The global glycine market encompasses the production and consumption of glycine in pharmaceutical, food, and technical grade forms, which are supplied to various industries, including healthcare, nutraceuticals, animal feed, food processing, cosmetics, and agrochemicals. Glycine serves as a key amino acid, used as an active pharmaceutical ingredient, a buffering agent, a flavor enhancer, and an intermediate in chemical synthesis. The market expansion is supported by growing demand for cost-effective amino acids, innovation in fermentation and synthetic production technologies, and wider distribution through global chemical supply chains that serve both regulated and commodity-driven end-use sectors.

Latest Market Trends

Expanding Pharmaceutical and Healthcare Applications

Glycine use in pharmaceutical and healthcare applications is steadily growing, driven by rising chronic disease prevalence and the large-scale production of generic drugs. It serves as an excipient, buffering agent, and active ingredient in antacids, injectable solutions, and amino-acid-based therapies. Demand is further supported by stricter quality standards, prompting manufacturers to invest in high-purity production. Its chemical stability, safety profile, and versatility make it a preferred input in cost-efficient treatments. This trend ensures steady demand and reinforces glycine’s foundational role in pharmaceutical manufacturing.

Rising Demand from Animal Nutrition and Feed Additives

Glycine demand in animal nutrition is increasing, driven by higher global meat consumption and intensifying livestock production. It is used as a feed additive to enhance protein efficiency, improve growth performance, and promote gut health in poultry and swine. Amino acid supplementation helps feed producers reduce overall protein content while maintaining nutritional quality, supporting cost efficiency and sustainability. As global demand for animal protein increases, glycine’s role in optimized feed formulations becomes more important, supporting volume growth and expanding market presence in key livestock regions.

To get more insights about this report Download Free Sample Report

Market Drivers

Growth in Pharmaceutical and Generic Drug Manufacturing

The expanding pharmaceutical sector, particularly in generic drug production, is a major driver of the glycine market. Its buffering properties, safety, and compatibility with multiple drug compounds make it essential in formulations for the management of chronic diseases. The rising incidence of conditions such as diabetes, cardiovascular disease, and gastrointestinal disorders increases the demand for affordable medications, driving the production volumes of glycine. Government policies promoting access to essential medicines further reinforce its importance. This structural reliance on glycine ensures consistent baseline demand, supporting the long-term stability and growth of the market in both emerging and developed economies.

Expanding Global Protein Consumption and Livestock Production

Rising global protein consumption is boosting demand for glycine in animal feed. Urbanization, higher incomes, and dietary shifts toward meat and poultry increase livestock production intensity. Glycine helps improve feed efficiency, reduce high-protein raw material costs, and support gut health, particularly in poultry and swine. This growing structural demand in animal nutrition provides a resilient driver for glycine, ensuring sustained volume growth and market expansion, particularly in high-consumption regions such as Asia-Pacific and Latin America.

Market Restraint

Price Volatility of Raw Materials

Glycine production is influenced by fluctuations in raw material costs, particularly those of petrochemical-based inputs and synthetic intermediates. Energy price volatility and supply chain disruptions can raise production costs, affecting profit margins, particularly for technical-grade glycine. Smaller producers may struggle to maintain profitability, while larger manufacturers invest in efficiency to mitigate cost pressures. Price fluctuations can also delay expansion plans and discourage investment in capacity growth. This uncertainty in input costs limits short-term profitability and restricts flexibility for new entrants, posing a key restraint in a price-sensitive market.

Market Opportunity

Advancements in Fermentation-Based Glycine Production

Fermentation-based glycine production offers growth opportunities by improving sustainability and reducing dependence on petrochemical inputs. Bio-based glycine has a lower environmental footprint and aligns with increasing demand for environmentally responsible sourcing. These innovations allow manufacturers to differentiate products, access premium markets, and meet customer sustainability goals. Fermentation-based processes also provide high-purity glycine suitable for pharmaceutical, nutraceutical, and food applications, supporting long-term competitiveness and enabling suppliers to strengthen their position in environmentally conscious and value-driven segments.

Regional Analysis

Asia Pacific dominated the market in 2025, accounting for 44.20% market share, supported by its strong manufacturing base, large-scale animal feed industry, and expanding pharmaceutical production. The region benefits from cost-efficient chemical synthesis, wide availability of raw materials, and high-volume demand from feed, food, and healthcare sectors. Rapid population growth, rising protein consumption, and industrial livestock farming continue to drive glycine usage in animal nutrition. Additionally, the region’s established export infrastructure further strengthens its global standing.

• China is the leading country in the Asia Pacific glycine market due to its large-scale chemical manufacturing ecosystem and strong export orientation. Domestic demand is reinforced by a rapidly expanding livestock sector and increasing pharmaceutical production. China’s cost advantages, integrated supply chains, and ongoing investments in fermentation-based production support both volume growth and gradual movement toward higher-value applications.

Middle East and Africa Glycine Market Insights

The Middle East and Africa is emerging as the fastest-growing region with a CAGR of 7.8% from 2026-2034. The expansion of animal feed industries, improvements in healthcare infrastructure, and increasing imports of pharmaceutical ingredients drive the growth. Urbanization, population growth, and increasing investment in food security programs support glycine consumption. While local production remains limited, import-based supply chains enable market development across key countries.

• Saudi Arabia is a leading market within MEA due to its expanding pharmaceutical manufacturing base and growing demand for animal nutrition products. Government initiatives to localize pharmaceutical production and improve food security support the use of glycine. Rising healthcare investments and industrial diversification further strengthen demand, positioning Saudi Arabia as a key growth market in the region.

Source: Straits Research

North America Market Insights

North America is driven by strong demand from the pharmaceuticals, clinical nutrition, and food processing industries. The region specializes in producing high-purity and pharmaceutical-grade glycine, supported by stringent quality and regulatory standards. Rising health awareness, aging populations, and growing use of amino acids in medical nutrition products contribute to stable demand. In animal nutrition, the adoption of glycine is supported by precision feeding practices and sustainability goals.

• The U.S. leads the North American glycine market due to its advanced pharmaceutical industry and high healthcare expenditure. Demand is supported by extensive use of glycine in injectable drugs, dietary supplements, and clinical nutrition products. Strong research activity, regulatory compliance capabilities, and long-term supplier relationships sustain market stability.

Europe Glycine Market Insights

Europe holds a significant share, driven by the pharmaceutical manufacturing, food processing, and regulated animal feed industries. The region places strong emphasis on quality, traceability, and environmental compliance, which favors established producers. Glycine demand is driven by its use in drug formulations, functional foods, and feed additives that support reduced protein formulations.

• Germany is the leading glycine market in Europe due to its strong pharmaceutical and specialty chemical sectors. The country’s advanced manufacturing standards and focus on high-purity ingredients support consistent demand. Glycine is widely used in drug formulation, laboratory reagents, and industrial applications. Germany’s role as a regional production and distribution hub further strengthens its position in the European glycine market.

Latin America Glycine Market Insights

Latin America is driven primarily by growth in animal feed and agro-industrial applications. Expanding poultry and livestock production, particularly in Brazil and Mexico, supports rising demand for feed-grade glycine. The region is gradually adopting amino acid supplementation to improve feed efficiency and reduce costs. While pharmaceutical demand remains limited compared to developed areas, improving healthcare access supports incremental growth.

• Brazil leads the Latin American glycine market due to its large livestock industry and strong agricultural exports. Glycine is increasingly used in feed formulations to enhance animal performance and sustainability. The country’s growing food processing and pharmaceutical sectors also contribute to demand. Continued modernization of feed practices and rising domestic consumption support steady market expansion.

Grade Insights

Pharmaceutical-grade glycine dominated the market, accounting for a revenue share of 38.4% in 2025, driven by its extensive use as an excipient, buffering agent, and active ingredient in drug formulations. This segment benefits from steady demand linked to the expansion of generic drug manufacturing, injectable therapies, and clinical nutrition products. Strict regulatory standards favor established producers with proven quality control, supporting stable pricing and long-term supply contracts.

Feed-grade glycine is the fastest-growing grade, expanding at a CAGR of 7.4%, driven by rising global meat consumption and increasing adoption of amino acid supplementation in animal nutrition. Livestock producers use glycine to improve feed efficiency, reduce protein costs, and support animal health. Rapid expansion of poultry and swine production in the Asia Pacific and Latin America further supports volume growth.

By Grade Market Share (%), 2025

Source: Straits Research

Application Insights

Pharmaceuticals and healthcare represented the largest application segment with an estimated 35% market share in 2025. Glycine’s role in drug formulations, injectable solutions, and clinical nutrition underpins consistent demand. The growth is supported by the expansion of generic drug manufacturing and the increasing use of hospital-based treatments. Regulatory acceptance and chemical stability make glycine a preferred ingredient across multiple dosage forms.

Animal feed and nutrition is the fastest-growing application segment, registering a CAGR of 7.6%. Rising protein consumption, urbanization, and industrial livestock farming are key drivers of growth. Glycine enhances growth performance and feed conversion ratios, making it a desirable option for large-scale producers. Environmental pressure to further reduce nitrogen emissions encourages amino acid supplementation, thereby reinforcing long-term demand growth in this segment.

Production Method Insights

Synthetic glycine production dominated the market, accounting for 65% of the market share in 2025, supported by established manufacturing infrastructure and cost efficiency at scale. Chemical synthesis allows consistent quality and high-volume output, making it suitable for feed and industrial applications. This segment is expected to grow, driven by stable demand from price-sensitive markets and industrial users.

Fermentation-based glycine is the fastest-growing production method, expanding at a CAGR of 8.2%, driven by sustainability concerns and demand for bio-based ingredients in regulated and premium applications. Fermentation offers lower environmental impact and aligns with clean-label and green chemistry trends. Increasing investment in biotechnology and process optimization supports rapid adoption across pharmaceutical and food applications.

Distribution Channel Insights

Direct B2B sales Pharmaceutical, feed, and chemical manufacturers prefer long-term supply agreements to ensure consistent quality, pricing stability, and regulatory compliance. This approach allows end-users to secure uninterrupted supply, manage inventory efficiently, and maintain stringent quality standards required for pharmaceutical- and food-grade glycine. Key suppliers leverage B2B relationships to offer bulk volumes and customized packaging, reinforcing customer loyalty.

Distributors and traders are the fastest-growing channel, registering a CAGR of 7.1%. This growth is fueled by expanding demand from small- and mid-sized manufacturers, as well as improved access to regional and remote markets. Distributors provide flexible order quantities, faster delivery, and localized support, enabling glycine suppliers to penetrate emerging economies and high-demand areas more effectively.

Competitive Landscape

The glycine market is moderately fragmented, characterized by a mix of large-scale chemical manufacturers, established pharmaceutical ingredient suppliers, and emerging bio-based producers. Established players dominate the market through scale efficiencies, long-standing customer relationships, and strict adherence to pharmaceutical and food-grade quality standards. Mid-tier producers and new entrants compete through cost optimization, fermentation-based production, and sustainability positioning, particularly in response to concerns about clean labels and the environment. Overall market momentum is supported by capacity expansions, long-term supply agreements, and increasing focus on specialty-grade and pharmaceutical-grade glycine.

Yuki Gosei Kogyo Co., Ltd.: A Heritage Innovator

Yuki Gosei Kogyo is a long-established Japanese producer of glycine, known for its strong presence in pharmaceutical and high-purity chemical applications. Its core strengths include precision manufacturing, strong R&D capabilities, and close collaboration with pharmaceutical customers. Yuki Gosei primarily serves high-value segments that demand stringent quality control, including injectable drugs and clinical formulations. Its production model emphasizes process optimization and gradual innovation rather than volume-driven competition, distinguishing it from bulk commodity suppliers.

Latest News:

• In June 2025, Yuki Gosei Kogyo announced incremental upgrades to its glycine purification facilities in Japan to enhance pharmaceutical-grade output and meet rising global demand.

List of key players in Glycine Market

1. GEO Specialty Chemicals
2. Evonik Industries AG
3. Ajinomoto Co., Inc.
4. Yuki Gosei Kogyo Co., Ltd.
5. Showa Denko K.K.
6. Chattem Chemicals (Sanofi Consumer Healthcare)
7. Shandong Xinhua Pharmaceutical Co., Ltd.
8. Hebei Donghua Jiheng Chemical Co., Ltd.
9. Jiangsu Kolod Food Ingredients Co., Ltd.
10. Chongqing Unisplendour Chemical Co., Ltd.
11. Baoding Mantong Fine Chemistry Co., Ltd.
12. Hubei Amino Acid Co., Ltd.
13. Newtrend Group
14. Paras Intermediates Pvt. Ltd.
15. Yuki Gosei Fine Chemicals (China operations)
16. Changzhou Jintan Maosheng Chemical Co., Ltd.
17. Shijiazhuang Donghua Jinlong Chemical Co., Ltd.
18. Foodchem International Corporation
19. Tokyo Chemical Industry Co., Ltd.
20. Merck KGaA
21. Thermo Fisher Scientific
22. Santa Cruz Biotechnology

To get more findings about this report Download Market Share

Strategic Initiatives

• February 2025 - Evonik Industries expanded its amino acid portfolio marketing in Asia to support pharmaceutical and nutrition customers seeking reliable, high-purity glycine sources, aligning with its specialty chemicals growth strategy.
• April 2025 - Ajinomoto announced targeted investments in fermentation technology aimed at improving the sustainability profile of its amino acid production, including glycine, supporting its long-term environmental commitments.